Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026)
Zevra Therapeutics (ZVRA) reported Long-Term Investments of $75.32 million for Q3 2026, up 144.0% from $30.87 million a year earlier and up 95.1% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics posted Long-Term Investments of $47.88 million, up 696.7% from FY2024.
- Long-Term Investments has a four-year compound annual growth rate of 33.8% (FY2021 to FY2025).
- By year, Long-Term Investments came in at $6.01 million in FY2024, $20 million in FY2022 (+33.9%) and $14.93 million in FY2021.
- The Q3 2026 figure ranks as the highest quarterly Long-Term Investments in data going back to Q2 2016.
- Year over year, Long-Term Investments has now increased in each of the last five quarters, with growth averaging 379.1% over the last five quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $38.61 million (Q2 2026), $36.15 million (Q1 2026) and $47.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 75.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 75.32 Mn |
| Jun 30, 2026 | 38.61 Mn |
| Mar 31, 2026 | 36.15 Mn |
| Dec 31, 2025 | 47.88 Mn |
| Sep 30, 2025 | 30.87 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.01 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 31.46 Mn |
| Jun 30, 2022 | 33.54 Mn |
| Mar 31, 2022 | 17.56 Mn |
| Dec 31, 2021 | 14.93 Mn |
| Dec 31, 2017 | 3.25 Mn |
| Sep 30, 2017 | 6.72 Mn |
| Jun 30, 2017 | 11.22 Mn |
| Mar 31, 2017 | 10.16 Mn |
| Dec 31, 2016 | 8.20 Mn |
| Sep 30, 2016 | 27.36 Mn |
API Access
Zevra Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();